Delcath Systems, Inc. (DCTH)
Delcath Systems, Inc., an interventional oncology company, focuses on the treatment of primary and metastatic liver cancers in the United States and Europe. The company's lead product candidate is HEPZATO KIT, a melphalan hydrochloride for injection/hepatic delivery system to administer high-dose chemotherapy to the liver while controlling systemic exposure and associated side effects. Its clinical development program for HEPZATO is the FOCUS clinical trial for patients with hepatic dominant ocular melanoma to investigate objective response rate in metastatic ocular melanoma. The company also provides HEPZATO as a stand-alone medical device for sale under the CHEMOSAT Hepatic Delivery System for Melphalan trade name for medical centers to treat a range of liver cancers in Europe. Delcath Systems, Inc. was incorporated in 1988 and is headquartered in New York, New York.
$259.55M
Mr. Gerard J. Michel MBA, MS
55.00
New York, NY
Oct 19, 2000
-3.68
$-2.52
1.20
2.55
-474.22%
-4.72
-0.33
63.47
22.11
2.04
-166.10%
-379.90%
Similar stocks (16)
TransMedics Group, Inc.
TMDX
Integer Holdings Corporation
ITGR
OrthoPediatrics Corp.
KIDS
Orthofix Medical Inc.
OFIX
IRadimed Corporation
IRMD
Surmodics, Inc.
SRDX
Treace Medical Concepts, Inc.
TMCI
Sight Sciences, Inc.
SGHT
Pulmonx Corporation
LUNG
ClearPoint Neuro, Inc.
CLPT
AVITA Medical, Inc.
RCEL
CVRx, Inc.
CVRX
NeuroPace, Inc.
NPCE
Electromed, Inc.
ELMD
TELA Bio, Inc.
TELA
Telesis Bio, Inc.
TBIO
ETF Exposure (12)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.711%
iShares Micro-Cap ETF
IWC
0.05782%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (16)
TransMedics Group, Inc.
TMDX
Integer Holdings Corporation
ITGR
OrthoPediatrics Corp.
KIDS
Orthofix Medical Inc.
OFIX
IRadimed Corporation
IRMD
Surmodics, Inc.
SRDX
Treace Medical Concepts, Inc.
TMCI
Sight Sciences, Inc.
SGHT
Pulmonx Corporation
LUNG
ClearPoint Neuro, Inc.
CLPT
AVITA Medical, Inc.
RCEL
CVRx, Inc.
CVRX
NeuroPace, Inc.
NPCE
Electromed, Inc.
ELMD
TELA Bio, Inc.
TELA
Telesis Bio, Inc.
TBIO
ETF Exposure (12)
Invesco NASDAQ Future Gen 200 ETF
QQQS
0.711%
iShares Micro-Cap ETF
IWC
0.05782%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%